chlorambucil has been researched along with Cutaneous T-Cell Lymphoma in 2 studies
Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Erythrodermic cutaneous T-cell lymphomas (CTCL) including Sézary syndrome have been successfully treated with daily administration of chlorambucil and prednisone (Winkelmann regimen)." | 9.09 | Treatment of erythrodermic cutaneous T-cell lymphoma with intermittent chlorambucil and fluocortolone therapy. ( Coors, EA; von den Driesch, P, 2000) |
| "Erythrodermic cutaneous T-cell lymphomas (CTCL) including Sézary syndrome have been successfully treated with daily administration of chlorambucil and prednisone (Winkelmann regimen)." | 5.09 | Treatment of erythrodermic cutaneous T-cell lymphoma with intermittent chlorambucil and fluocortolone therapy. ( Coors, EA; von den Driesch, P, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murphy, A | 1 |
| O'Keane, JC | 1 |
| Blayney, A | 1 |
| Powell, FC | 1 |
| Coors, EA | 1 |
| von den Driesch, P | 1 |
1 review available for chlorambucil and Cutaneous T-Cell Lymphoma
| Article | Year |
|---|---|
Cutaneous presentation of nasal lymphoma: a report of two cases.
Topics: Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chlorambuci | 1998 |
1 trial available for chlorambucil and Cutaneous T-Cell Lymphoma
| Article | Year |
|---|---|
Treatment of erythrodermic cutaneous T-cell lymphoma with intermittent chlorambucil and fluocortolone therapy.
Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Chlorambucil; Disease-Free Surviv | 2000 |